Pharmafile Logo
Pharmafocus logo
Advanced Search

peanut allergy

Showing 3 posts of 3 posts found.

15031804271_3791dafae1_b

FDA approves first treatment for peanut allergy

February 3, 2020
Sales and Marketing FDA, FDA Peanuts, peanut, peanut allergy, peanut medicine

The FDA has approved its first treatment for peanut allergy in patients between ages four and 17. The drug is …

News
peanuts_nuts_snack_nutrition_healthy_nibble_decoration_close-842313

Aimmune’s peanut allergy therapy recommended for approval by FDA committee

September 16, 2019
Sales and Marketing Aimmune, FDA, peanut allergy, pharma

The FDA’s Allergenic Products Advisory Committee (APAC) has recommended the use of Aimmune Therapeutics’ AR101, also known by its proposed …

News
peanuts_nuts_snack_nutrition_healthy_nibble_decoration_close-842313

Aimmune’s peanut allergy candidate hits main endpoint at Phase 3

February 21, 2018
Research and Development Aimmune, peanut, peanut allergy, pharma

US biopharmaceutical firm Aimmune has revealed that its peanut allergy candidate AR101 hit its primary endpoint in the largest trial …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024